关注
Ahmet Krasniqi
Ahmet Krasniqi
未知所在单位机构
在 vub.be 的电子邮件经过验证
标题
引用次数
引用次数
年份
Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle
Y Dekempeneer, M Keyaerts, A Krasniqi, J Puttemans, S Muyldermans, ...
Expert opinion on biological therapy 16 (8), 1035-1047, 2016
1622016
Same-day imaging using small proteins: clinical experience and translational prospects in oncology
A Krasniqi, M D’Huyvetter, N Devoogdt, FY Frejd, J Sörensen, A Orlova, ...
Journal of Nuclear Medicine 59 (6), 885-891, 2018
1282018
Theranostic radiolabeled anti-CD20 sdAb for targeted radionuclide therapy of non-Hodgkin lymphoma
A Krasniqi, M D'Huyvetter, C Xavier, K Van der Jeught, S Muyldermans, ...
Molecular cancer therapeutics 16 (12), 2828-2839, 2017
752017
Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix)
AC Guardo, PT Joe, L Miralles, ME Bargalló, B Mothe, A Krasniqi, ...
Aids 31 (3), 321-332, 2017
482017
Evaluation of [99mTc]Radiolabeled Macrophage Mannose Receptor-Specific Nanobodies for Targeting of Atherosclerotic Lesions in Mice
G Bala, H Baudhuin, I Remory, K Gillis, P Debie, A Krasniqi, T Lahoutte, ...
Molecular Imaging and Biology 20, 260-267, 2018
282018
Stromal-targeting radioimmunotherapy mitigates the progression of therapy-resistant tumors
E Bolli, M D’Huyvetter, A Murgaski, D Berus, G Stangé, EJ Clappaert, ...
Journal of Controlled Release 314, 1-11, 2019
272019
Pharmacokinetics of radiolabeled dimeric sdAbs constructs targeting human CD20
A Krasniqi, M Bialkowska, C Xavier, K Van der Jeught, S Muyldermans, ...
New biotechnology 45, 69-79, 2018
232018
Identification of nanobodies against the acute myeloid leukemia marker CD33
E Romão, A Krasniqi, L Maes, C Vandenbrande, YGJ Sterckx, ...
International journal of molecular sciences 21 (1), 310, 2020
202020
A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma
E Duray, M Lejeune, F Baron, Y Beguin, N Devoogdt, A Krasniqi, ...
Journal of hematology & oncology 14, 1-13, 2021
162021
Emerging applications of nanobodies in cancer therapy
RM Awad, F Meeus, H Ceuppens, T Ertveldt, H Hanssens, Q Lecocq, ...
International review of cell and molecular biology 369, 143-199, 2022
142022
CS1-specific single-domain antibodies labeled with Actinium-225 prolong survival and increase CD8+ T cells and PD-L1 expression in Multiple Myeloma
K De Veirman, J Puttemans, A Krasniqi, T Ertveldt, H Hanssens, E Romao, ...
Oncoimmunology 10 (1), 2000699, 2021
122021
Targeted α-therapy using 225Ac radiolabeled single-domain antibodies induces antigen-specific immune responses and instills immunomodulation both systemically and at the tumor …
T Ertveldt, A Krasniqi, H Ceuppens, J Puttemans, Y Dekempeneer, ...
Journal of Nuclear Medicine 64 (5), 751-758, 2023
92023
Targeted radionuclide therapy with low and high-dose lutetium-177–labeled single domain antibodies induces distinct immune signatures in a mouse melanoma model
T Ertveldt, L De Beck, K De Ridder, H Locy, W De Mey, C Goyvaerts, ...
Molecular Cancer Therapeutics 21 (7), 1136-1148, 2022
82022
Radiotheranostic agents in hematological malignancies
J Caers, E Duray, L Vrancken, G Marcion, V Bocuzzi, K De Veirman, ...
Frontiers in Immunology 13, 911080, 2022
52022
Newer Bioconjugation Methods
A Krasniqi, C Xavier, N Devoogdt
Molecular Imaging, 517-529, 2021
12021
Advancing Surgical Arrhythmia Ablation: Novel Insights on 3D Printing Applications and Two Biocompatible Materials
C Monaco, R Kronenberger, G Talevi, L Pannone, IA Cappello, ...
Biomedicines 12 (4), 869, 2024
2024
Accepted poster session at ImmunoRad 2023: Targeted alpha therapy using Actinium-225 radiolabeled single domain antibodies induces antigen-specific immune responses and …
T Ertveldt, A Krasniqi, H Ceuppens, J Puttemans, Y Dekempeneer, ...
ImmunoRad 2023: The International Conference on Immunotherapy Radiotherapy …, 2023
2023
Targeted alpha therapy using Actinium-225 radiolabeled single domain antibodies induces antigen-specific immune responses and instills immunomodulation both systemically and at …
T Ertveldt, K Breckpot, N Devoogdt, J Puttemans, K De Veirman, ...
2022
The therapeutic potential of Actinium-225-labeled CS1-specific single-domain antibodies for the treatment of Multiple Myeloma
K De Veirman, J Puttemans, A Krasniqi, H Hanssens, E Romao, ...
Nanobodies: Hybrid 2nd edition-VIB, 2021
2021
Investigating immune activation upon beta targeted radionuclide therapy using anti-CD20 single domain antibody fragments in melanoma
T Ertveldt, Y Dekempeneer, L De Beck, C Goyvaerts, Q Lecocq, ...
BACR Annual Meeting 2020: Cancer metastasis: From bedside to bench, 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–20